Literature DB >> 391463

Drug kinetics and hepatic blood flow.

C F George.   

Abstract

Mesh：

Substances：

Year:  1979        PMID： 391463     DOI： 10.2165/00003088-197904060-00003

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  68 in total

1.  Pharmacokinetics of oxprenolol in normal subjects.

Authors:  W D Mason; N Winer
Journal:  Clin Pharmacol Ther       Date:  1976-10       Impact factor: 6.875

2.  Changes in cardiac output with age.

Authors:  M BRANDFONBRENER; M LANDOWNE; N W SHOCK
Journal:  Circulation       Date:  1955-10       Impact factor: 29.690

3.  Enterohepatic circulation of bromsulphalein: intraduodenal, intraportal and intravenous dye administration in dogs.

Authors:  S H LORBER; M J OPPENHEIMER; H SHAY; P LYNCH; H SIPLET
Journal:  Am J Physiol       Date:  1953-05

4.  The effect of the upright posture upon hepatic blood flow in normotensive and hypertensive subjects.

Authors:  J W CULBERTSON; R W WILKINS; F J INGELFINGER; S E BRADLEY
Journal:  J Clin Invest       Date:  1951-03       Impact factor: 14.808

5.  Enhancement of the bioavailability of propranolol and metoprolol by food.

Authors:  A Melander; K Danielson; B Scherstén; E Wåhlin
Journal:  Clin Pharmacol Ther       Date:  1977-07       Impact factor: 6.875

6.  Impaired Lignocaine metabolism in patients with myocardial infarction and cardiac failure.

Authors:  L F Prescott; K K Adjepon-Yamoah; R G Talbot
Journal:  Br Med J       Date:  1976-04-17

7.  Physiological disposition of verapamil in man.

Authors:  M Schomerus; B Spiegelhalder; B Stieren; M Eichelbaum
Journal:  Cardiovasc Res       Date:  1976-09       Impact factor: 10.787

8.  Pharmacokinetics of methohexitone following intravenous infusion in humans.

Authors:  D D Breimer
Journal:  Br J Anaesth       Date:  1976-07       Impact factor: 9.166

9.  Influence of congestive heart failure on prazosin kinetics.

Authors:  P Jaillon; P Rubin; Y G Yee; R Ball; R Kates; D Harrison; T Blaschke
Journal:  Clin Pharmacol Ther       Date:  1979-06       Impact factor: 6.875

10.  Metabolism of labetalol by animals and man.

Authors:  L E Martin; R Hopkins; R Bland
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335
View more
  38 in total

1.  Potentially lethal interaction of cimetidine and morphine.

Authors:  P Mojaverian; B N Swanson; P H Vlasses; R K Ferguson
Journal:  Can Med Assoc J       Date:  1981-12-01       Impact factor: 8.262

2.  Acute effects of felodipine and nifedipine on hepatic and forearm blood flow in healthy men.

Authors:  B Bengtsson-Hasselgren; O Rönn; L O Blychert; B Edgar; S Raner
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 3.  Therapeutic drug monitoring in pregnancy: rationale and current status.

Authors:  C Knott; F Reynolds
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

4.  Age-related changes in the pharmacokinetics and pharmacodynamics of nifedipine.

Authors:  D R Robertson; D G Waller; A G Renwick; C F George
Journal:  Br J Clin Pharmacol       Date:  1988-03       Impact factor: 4.335

5.  Variability in biological monitoring of solvent exposure. I. Development of a population physiological model.

Authors:  P O Droz; M M Wu; W G Cumberland; M Berode
Journal:  Br J Ind Med       Date:  1989-07

Review 6.  Clinical pharmacokinetics of labetalol.

Authors:  J J McNeil; W J Louis
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

7.  Drug metabolism by the gastrointestinal mucosa.

Authors:  C F George
Journal:  Clin Pharmacokinet       Date:  1981 Jul-Aug       Impact factor: 6.447

Review 8.  Labetalol. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in hypertension and ischaemic heart disease.

Authors:  K L Goa; P Benfield; E M Sorkin
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

Review 9.  Clinical pharmacokinetics and kinetic-dynamic relationships of dilevalol and labetalol.

Authors:  R Donnelly; G J Macphee
Journal:  Clin Pharmacokinet       Date:  1991-08       Impact factor: 6.447

10.  Interaction study between nifedipine and recombinant tissue-type plasminogen activator in healthy subjects.

Authors:  A De Boer; C Kluft; F J Kasper; J M Kroon; H C Schoemaker; D D Breimer; P A Soons; A F Cohen
Journal:  Br J Clin Pharmacol       Date:  1993-08       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.